NCT03425279

CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma

Public trial-level signal summary for this oncology Phase 2 record.

Record overview

Status and phase

Status: COMPLETED

Phase: PHASE1, PHASE2

Sponsor: BioAtla, Inc.

Condition: Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma

Signal summary

Public flags

Status signal: Low Signal

Timeline signals: None

Results signal: Completed No Results Found Signal

Operational burden: large_enrollment_target_signal | strict_eligibility_signal

Stopped reason

Context when available

No stop reason available in the current public record.